The goal of this activity is for learners to be better able to decipher the role of systemic inflammation in the development of atherosclerotic cardiovascular disease (ASCVD) and evaluate current and emerging therapeutic strategies that address residual inflammatory risk for cardiovascular (CV) risk reduction in order to optimize the outcomes of patients with heightened inflammatory risk.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1001532
- Start Date: 2024-08-28 05:00:00
- End Date: 2024-08-28 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.25 hours
Nursing: 1.25 hours - MOC Credit Details: ABIM - 1.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Novo Nordisk (Any division) - Amount: 83792.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Cardiovascular Disease, Internal Medicine, Interventional Cardiology
Subscribe
Login
0 Comments
Oldest